0001973141-24-000207.txt : 20240402 0001973141-24-000207.hdr.sgml : 20240402 20240402161447 ACCESSION NUMBER: 0001973141-24-000207 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240402 DATE AS OF CHANGE: 20240402 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Syros Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001556263 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 453772460 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-37813 FILM NUMBER: 24814361 BUSINESS ADDRESS: STREET 1: 35 CAMBRIDGE PARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 BUSINESS PHONE: 617-744-1340 MAIL ADDRESS: STREET 1: 35 CAMBRIDGE PARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 FORMER COMPANY: FORMER CONFORMED NAME: LS22, Inc. DATE OF NAME CHANGE: 20120815 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Roth David CENTRAL INDEX KEY: 0001599014 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O SYROS PHARMACEUTICALS, INC. STREET 2: 620 MEMORIAL DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02139 144 1 primary_doc.xml 144 0001599014 XXXXXXXX LIVE 0001556263 Syros Pharmaceuticals, Inc. 001-37813 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 617-744-1340 Roth David Officer Common UBS Financial Services Inc.

1000 Harbor Boulevard Weehawken NJ 07086

150 747.04 26453891 04/02/2024 NASDAQ Common 04/01/2024 Restricted Stock Units Issuer N 150 04/01/2024 N/A Y 04/02/2024 03/27/2023 /s/ UBS Financial Services Inc, as attorney-in-fact for David Roth